Nucleoli in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia treated with cytostatic drugs

Quantitative and morphological changes of the nucleoli in the lymphocytes were studied in patients with chronic lymphocytic leukemia treated with cyclophosphamide and vinblastine, and were compared with the lymphocytes of patients treated with leukeran and healthy subjects. The nucleolar index was 1...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Archivum Immunologiae et Therapiae Experimentalis Ročník 31; číslo 4; s. 481
Hlavní autoři: Kopeć, J, Sitarska, E, Leszko, B
Médium: Journal Article
Jazyk:angličtina
Vydáno: Switzerland 1983
Témata:
ISSN:0004-069X
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Quantitative and morphological changes of the nucleoli in the lymphocytes were studied in patients with chronic lymphocytic leukemia treated with cyclophosphamide and vinblastine, and were compared with the lymphocytes of patients treated with leukeran and healthy subjects. The nucleolar index was 1.20 in the lymphocytes of patients with chronic lymphocytic leukemia in stages II, III and IV of the disease, according to Rai's classification, and it showed no significant correlation with the mode and effect of treatment. The index was significantly higher than in the lymphocytes of healthy subjects (p less than 0.05). The activity of nucleoli in the lymphocytes of the patients treated with cyclophosphamide with vinblastine was significantly higher than in the leukeran-treated patients and healthy subjects, and it increased with progression of the disease and with successive passage from stage II to III and IV. In the patients in whom clinical improvement was achieved and the treatment with cytostatics was withdrawn, the proportion of active nucleoli in the lymphocytes was decreased.
AbstractList Quantitative and morphological changes of the nucleoli in the lymphocytes were studied in patients with chronic lymphocytic leukemia treated with cyclophosphamide and vinblastine, and were compared with the lymphocytes of patients treated with leukeran and healthy subjects. The nucleolar index was 1.20 in the lymphocytes of patients with chronic lymphocytic leukemia in stages II, III and IV of the disease, according to Rai's classification, and it showed no significant correlation with the mode and effect of treatment. The index was significantly higher than in the lymphocytes of healthy subjects (p less than 0.05). The activity of nucleoli in the lymphocytes of the patients treated with cyclophosphamide with vinblastine was significantly higher than in the leukeran-treated patients and healthy subjects, and it increased with progression of the disease and with successive passage from stage II to III and IV. In the patients in whom clinical improvement was achieved and the treatment with cytostatics was withdrawn, the proportion of active nucleoli in the lymphocytes was decreased.
Quantitative and morphological changes of the nucleoli in the lymphocytes were studied in patients with chronic lymphocytic leukemia treated with cyclophosphamide and vinblastine, and were compared with the lymphocytes of patients treated with leukeran and healthy subjects. The nucleolar index was 1.20 in the lymphocytes of patients with chronic lymphocytic leukemia in stages II, III and IV of the disease, according to Rai's classification, and it showed no significant correlation with the mode and effect of treatment. The index was significantly higher than in the lymphocytes of healthy subjects (p less than 0.05). The activity of nucleoli in the lymphocytes of the patients treated with cyclophosphamide with vinblastine was significantly higher than in the leukeran-treated patients and healthy subjects, and it increased with progression of the disease and with successive passage from stage II to III and IV. In the patients in whom clinical improvement was achieved and the treatment with cytostatics was withdrawn, the proportion of active nucleoli in the lymphocytes was decreased.Quantitative and morphological changes of the nucleoli in the lymphocytes were studied in patients with chronic lymphocytic leukemia treated with cyclophosphamide and vinblastine, and were compared with the lymphocytes of patients treated with leukeran and healthy subjects. The nucleolar index was 1.20 in the lymphocytes of patients with chronic lymphocytic leukemia in stages II, III and IV of the disease, according to Rai's classification, and it showed no significant correlation with the mode and effect of treatment. The index was significantly higher than in the lymphocytes of healthy subjects (p less than 0.05). The activity of nucleoli in the lymphocytes of the patients treated with cyclophosphamide with vinblastine was significantly higher than in the leukeran-treated patients and healthy subjects, and it increased with progression of the disease and with successive passage from stage II to III and IV. In the patients in whom clinical improvement was achieved and the treatment with cytostatics was withdrawn, the proportion of active nucleoli in the lymphocytes was decreased.
Author Leszko, B
Kopeć, J
Sitarska, E
Author_xml – sequence: 1
  givenname: J
  surname: Kopeć
  fullname: Kopeć, J
– sequence: 2
  givenname: E
  surname: Sitarska
  fullname: Sitarska, E
– sequence: 3
  givenname: B
  surname: Leszko
  fullname: Leszko, B
BackLink https://www.ncbi.nlm.nih.gov/pubmed/6670918$$D View this record in MEDLINE/PubMed
BookMark eNpF0EtLxDAUBeAsRsaZ0Z8gZOWukEcf6VIGXzDoRsFdSZNbG02bmKRI_70zTMHVPQc-zuJu0Wp0I6zQhhCSZ6SsPy7RNsavY-MFzddoXZYVqanYoPQyKQvOGmxG7CEY30OQFrfWOY3tPPjeqTlBxK7DXiYDY4r416Qeqz640ah_dMowfcNgJE4BZAK9yDm5mOQJ6DB9xit00Ukb4Xq5O_T-cP-2f8oOr4_P-7tD5hkpUwZMK6aAqqoDSXWrKeWq1Z2seQt5wZgmBada1iBaUnNNuS5KTkRR8RJULtkO3Z53fXA_E8TUDCYqsFaO4KbYCCIE5Xl-hDcLnNoBdOODGWSYm-VN7A_kW2i8
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Biology
ExternalDocumentID 6670918
Genre Journal Article
GroupedDBID ---
-56
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
203
23N
29~
2J2
2JY
2KG
2KM
2LR
2VQ
2~H
30V
3V.
4.4
406
408
40D
40E
53G
5GY
5RE
5VS
67Z
6NX
7X7
88E
8AO
8FE
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
9WM
AAAVM
AABHQ
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AATOW
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABDZT
ABECU
ABFKT
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABMXE
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABUWG
ABWNU
ABXPI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACSNA
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEXYK
AFBBN
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHGSO
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BAWUL
BBNVY
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
CGR
COF
CS3
CSCUP
CUY
CVF
DIK
DNIVK
DPUIP
E3Z
EBD
EBS
ECM
EIF
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
H13
HCIFZ
HF~
HG5
HG6
HLICF
HMCUK
HMJXF
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
IWAJR
IXC
IXD
IXE
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KDC
KOV
KPH
LAS
LK8
LLZTM
M1P
M4Y
M7P
MA-
N2Q
NB0
NPM
NQJWS
NU0
O9-
O93
O9I
O9J
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
Q2X
QD8
QOR
QOS
R89
R9I
ROL
RPX
RSV
S16
S1Z
S27
S37
S3B
SAP
SBL
SDH
SHX
SISQX
SLJYH
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WK8
Y2W
YLTOR
Z45
Z7U
Z82
Z87
ZGI
ZMTXR
ZOVNA
~A9
~KM
7X8
ID FETCH-LOGICAL-p206t-e2dc2ce1c7fea1dbd113cbdfa93be4522d0531da9e8b093d13d563085736ec4a2
IEDL.DBID 7X8
ISICitedReferencesCount 3
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=6670918&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0004-069X
IngestDate Thu Sep 04 19:19:16 EDT 2025
Wed Feb 19 01:08:31 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-p206t-e2dc2ce1c7fea1dbd113cbdfa93be4522d0531da9e8b093d13d563085736ec4a2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 6670918
PQID 80881344
PQPubID 23479
ParticipantIDs proquest_miscellaneous_80881344
pubmed_primary_6670918
PublicationCentury 1900
PublicationDate 1983-00-00
19830101
PublicationDateYYYYMMDD 1983-01-01
PublicationDate_xml – year: 1983
  text: 1983-00-00
PublicationDecade 1980
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Archivum Immunologiae et Therapiae Experimentalis
PublicationTitleAlternate Arch Immunol Ther Exp (Warsz)
PublicationYear 1983
SSID ssj0043514
Score 1.2606333
Snippet Quantitative and morphological changes of the nucleoli in the lymphocytes were studied in patients with chronic lymphocytic leukemia treated with...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 481
SubjectTerms Cell Nucleolus - drug effects
Cell Nucleolus - metabolism
Cell Nucleolus - pathology
Chlorambucil - therapeutic use
Cyclophosphamide - therapeutic use
Drug Therapy, Combination
Humans
Leukemia, Lymphoid - blood
Leukemia, Lymphoid - drug therapy
Leukemia, Lymphoid - pathology
Lymphocytes - drug effects
Lymphocytes - pathology
Neoplasm Staging
Vinblastine - therapeutic use
Title Nucleoli in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia treated with cytostatic drugs
URI https://www.ncbi.nlm.nih.gov/pubmed/6670918
https://www.proquest.com/docview/80881344
Volume 31
WOSCitedRecordID wos6670918&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA6rq-DF9-L6zMFrsW2yTQqCiLh4sXhQ6K2kyUQW13bddoX-e5O01ZN48FJ6mEDJPDKdmXwfQpeMMH-ifOn5hGmPSjAuJWnkMRGBoMqd4o5sgiUJT9P4aYCu-7swdqyyj4kuUKtS2hr5FTfuEBBKbxYfnuWMsr3VjkBjDQ2JSWSsTbP0u4dASYfs7UYtojj9PYd0Z8l0539fsYu2uxwS37ZK30MDKPbRZssq2RygOrEYxeV8hmcFtkDGDjlgjt2MOp43Rn-lbEyKiUuNO1zVCtuCLJYtVO6PkH2H1Ru8zwR2M-mgOsmmLu1lJCOglqvX6hC9TO-f7x68jlzBW4R-VHsQKhlKCCTTIAKVqyAgMldaxCQHC7OurHsqEQPP_ZiogCgLJcYnjEQgqQhHaL0oCzhCWJl_tpBzrUk0oULn3MTMkBjrMCoAIWCMLvrNzIzx2o6EKKBcVVm_nWM0avWRLVqMjSyyuHIBP_5z6QnaCmJO2qrIKRpq47VwhjbkZz2rlufOJMwzeXr8AoqcyMQ
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nucleoli+in+peripheral+blood+lymphocytes+of+patients+with+chronic+lymphocytic+leukemia+treated+with+cytostatic+drugs&rft.jtitle=Archivum+Immunologiae+et+Therapiae+Experimentalis&rft.au=Kope%C4%87%2C+J&rft.au=Sitarska%2C+E&rft.au=Leszko%2C+B&rft.date=1983-01-01&rft.issn=0004-069X&rft.volume=31&rft.issue=4&rft.spage=481&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-069X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-069X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-069X&client=summon